Intelligence Hub
Market analytics and operational performance indicators
Ownership Report - November 4, 2024
Vanguard Group holds 7.15% of Rocket Lab shares as of Sept 30, 2024.
Brief
This SC 13G/A (Amendment No. 2) discloses The Vanguard Group's beneficial ownership in Rocket Lab USA Inc. common stock. As of September 30, 2024, Vanguard reports owning 35,527,484 shares, or 7.15% of the class, primarily with sole dispositive power. Relevant to investors as it confirms a major passive institutional stake.
Detailed Brief
The Vanguard Group, a Pennsylvania-based investment adviser, filed this Amendment No. 2 to Schedule 13G under Rule 13d-1(b) on November 4, 2024, reporting its position as of September 30, 2024, in Rocket Lab USA Inc. (NASDAQ: RKLB) common stock (CUSIP 773122106). Vanguard beneficially owns 35,527,484 shares (7.15%), with 0 sole voting power, 628,723 shared voting power, 34,525,078 sole dispositive power, and 1,002,406 shared dispositive power. Ownership is on behalf of clients like mutual funds, with no single client exceeding 5%. As a passive filer, Vanguard has no intent to influence or control Rocket Lab, a space launch company based in Long Beach, CA. This update maintains their above-5% disclosure obligation.
Key Telemetry
- • Vanguard beneficially owns 35,527,484 RKLB shares (7.15%) as of 9/30/2024.
- • Sole dispositive power over 34,525,078 shares; shared voting power 628,723 shares.
- • Filed as passive investor (Rule 13d-1(b)); clients own shares, no single >5%.
- • Amendment No. 2; prior filings tracked changes crossing 5% thresholds.
Impact Vector
This filing signals sustained institutional confidence from Vanguard, a top asset manager, in Rocket Lab's growth as a space launch provider, but as a passive 13G stake, it implies no activist pressure or control intent. Near-term, it supports stock stability amid volatility; strategically, high institutional ownership (7%+) aids liquidity. Investors should monitor future 13G/13D amendments for position shifts above/below 5% or conversion to active 13D.